{"disease":{"id":"chemo-brain","name":"chemo brain"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06687291","title":"Cognitive Impact Associated With Surgery For Gastric Or Esophageal Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":130,"lead_sponsor_name":"Karolinska Institutet","has_results":false},{"nct_id":"NCT06662474","title":"Cognitive Impairment in Treated Breast Cancer Survivors: Possible Approaches","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":120,"lead_sponsor_name":"Grigore T. Popa University of Medicine and Pharmacy","has_results":false},{"nct_id":"NCT05840575","title":"Investigating Cognitive Impairment in Young Patients With Cancer Prospectively","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Rigshospitalet, Denmark","has_results":false},{"nct_id":"NCT05305092","title":"Assessment of Brain Cognitive Impairment in Breast Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":90,"lead_sponsor_name":"Tang-Du Hospital","has_results":false},{"nct_id":"NCT07454473","title":"Edaravone and Dexborneol Sublingual Tablet for Treating Chemotherapy- Induced Cognitive Impairment Study","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"Chuansheng Zhao","has_results":false},{"nct_id":"NCT05864274","title":"Improve Cancer-related Cognitive Impairment","phase":"NA","overall_status":"RECRUITING","enrollment_count":64,"lead_sponsor_name":"University of Alabama at Birmingham","has_results":false},{"nct_id":"NCT04033419","title":"Memantine for Prevention of Cognitive Decline in Patients With Breast Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":55,"lead_sponsor_name":"UNC Lineberger Comprehensive Cancer Center","has_results":true},{"nct_id":"NCT05283629","title":"nCCR for Chemotherapy Related Cognitive Impairment Randomized Study","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":50,"lead_sponsor_name":"University of Massachusetts, Worcester","has_results":false},{"nct_id":"NCT04295720","title":"Treatment of Post-Chemo Cognitive Impairment w/Transcranial Magnetic Stimulation (Chemobrain TMS)","phase":"NA","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"University of Arizona","has_results":true}],"total":9},"guidelines":[],"source":"Drug Landscape verified database"}